Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule CXO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 CRO
1.2.3 CMC
1.2.4 CDMO
1.2.5 CMO
1.3 Market by Application
1.3.1 Global Small Molecule CXO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule CXO Market Perspective (2018-2033)
2.2 Global Small Molecule CXO Growth Trends by Region
2.2.1 Small Molecule CXO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Small Molecule CXO Historic Market Size by Region (2018-2023)
2.2.3 Small Molecule CXO Forecasted Market Size by Region (2024-2033)
2.3 Small Molecule CXO Market Dynamics
2.3.1 Small Molecule CXO Industry Trends
2.3.2 Small Molecule CXO Market Drivers
2.3.3 Small Molecule CXO Market Challenges
2.3.4 Small Molecule CXO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Small Molecule CXO by Players
3.1.1 Global Small Molecule CXO Revenue by Players (2018-2023)
3.1.2 Global Small Molecule CXO Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Small Molecule CXO, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Small Molecule CXO Market Concentration Ratio
3.4.1 Global Small Molecule CXO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CXO Revenue in 2022
3.5 Global Key Players of Small Molecule CXO Head office and Area Served
3.6 Global Key Players of Small Molecule CXO, Product and Application
3.7 Global Key Players of Small Molecule CXO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule CXO Breakdown Data by Type
4.1 Global Small Molecule CXO Historic Market Size by Type (2018-2023)
4.2 Global Small Molecule CXO Forecasted Market Size by Type (2024-2033)
5 Small Molecule CXO Breakdown Data by Application
5.1 Global Small Molecule CXO Historic Market Size by Application (2018-2023)
5.2 Global Small Molecule CXO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Small Molecule CXO Market Size (2018-2033)
6.2 North America Small Molecule CXO Market Size by Type
6.2.1 North America Small Molecule CXO Market Size by Type (2018-2023)
6.2.2 North America Small Molecule CXO Market Size by Type (2024-2033)
6.2.3 North America Small Molecule CXO Market Share by Type (2018-2033)
6.3 North America Small Molecule CXO Market Size by Application
6.3.1 North America Small Molecule CXO Market Size by Application (2018-2023)
6.3.2 North America Small Molecule CXO Market Size by Application (2024-2033)
6.3.3 North America Small Molecule CXO Market Share by Application (2018-2033)
6.4 North America Small Molecule CXO Market Size by Country
6.4.1 North America Small Molecule CXO Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Small Molecule CXO Market Size by Country (2018-2023)
6.4.3 North America Small Molecule CXO Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Small Molecule CXO Market Size (2018-2033)
7.2 Europe Small Molecule CXO Market Size by Type
7.2.1 Europe Small Molecule CXO Market Size by Type (2018-2023)
7.2.2 Europe Small Molecule CXO Market Size by Type (2024-2033)
7.2.3 Europe Small Molecule CXO Market Share by Type (2018-2033)
7.3 Europe Small Molecule CXO Market Size by Application
7.3.1 Europe Small Molecule CXO Market Size by Application (2018-2023)
7.3.2 Europe Small Molecule CXO Market Size by Application (2024-2033)
7.3.3 Europe Small Molecule CXO Market Share by Application (2018-2033)
7.4 Europe Small Molecule CXO Market Size by Country
7.4.1 Europe Small Molecule CXO Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Small Molecule CXO Market Size by Country (2018-2023)
7.4.3 Europe Small Molecule CXO Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Small Molecule CXO Market Size (2018-2033)
8.2 China Small Molecule CXO Market Size by Type
8.2.1 China Small Molecule CXO Market Size by Type (2018-2023)
8.2.2 China Small Molecule CXO Market Size by Type (2024-2033)
8.2.3 China Small Molecule CXO Market Share by Type (2018-2033)
8.3 China Small Molecule CXO Market Size by Application
8.3.1 China Small Molecule CXO Market Size by Application (2018-2023)
8.3.2 China Small Molecule CXO Market Size by Application (2024-2033)
8.3.3 China Small Molecule CXO Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Small Molecule CXO Market Size (2018-2033)
9.2 Asia Small Molecule CXO Market Size by Type
9.2.1 Asia Small Molecule CXO Market Size by Type (2018-2023)
9.2.2 Asia Small Molecule CXO Market Size by Type (2024-2033)
9.2.3 Asia Small Molecule CXO Market Share by Type (2018-2033)
9.3 Asia Small Molecule CXO Market Size by Application
9.3.1 Asia Small Molecule CXO Market Size by Application (2018-2023)
9.3.2 Asia Small Molecule CXO Market Size by Application (2024-2033)
9.3.3 Asia Small Molecule CXO Market Share by Application (2018-2033)
9.4 Asia Small Molecule CXO Market Size by Region
9.4.1 Asia Small Molecule CXO Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Small Molecule CXO Market Size by Region (2018-2023)
9.4.3 Asia Small Molecule CXO Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Small Molecule CXO Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Type
10.2.1 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Small Molecule CXO Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Application
10.3.1 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Small Molecule CXO Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Country
10.4.1 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Small Molecule CXO Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Small Molecule CXO Introduction
11.1.4 IQVIA Revenue in Small Molecule CXO Business (2018-2023)
11.1.5 IQVIA Recent Developments
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Small Molecule CXO Introduction
11.2.4 Labcorp Revenue in Small Molecule CXO Business (2018-2023)
11.2.5 Labcorp Recent Developments
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Small Molecule CXO Introduction
11.3.4 PPD Revenue in Small Molecule CXO Business (2018-2023)
11.3.5 PPD Recent Developments
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Details
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec Small Molecule CXO Introduction
11.4.4 Wuxi Apptec Revenue in Small Molecule CXO Business (2018-2023)
11.4.5 Wuxi Apptec Recent Developments
11.5 PharmaBlock
11.5.1 PharmaBlock Company Details
11.5.2 PharmaBlock Business Overview
11.5.3 PharmaBlock Small Molecule CXO Introduction
11.5.4 PharmaBlock Revenue in Small Molecule CXO Business (2018-2023)
11.5.5 PharmaBlock Recent Developments
11.6 Asym Chemical
11.6.1 Asym Chemical Company Details
11.6.2 Asym Chemical Business Overview
11.6.3 Asym Chemical Small Molecule CXO Introduction
11.6.4 Asym Chemical Revenue in Small Molecule CXO Business (2018-2023)
11.6.5 Asym Chemical Recent Developments
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Details
11.7.2 Jiuzhou Pharmaceutical Business Overview
11.7.3 Jiuzhou Pharmaceutical Small Molecule CXO Introduction
11.7.4 Jiuzhou Pharmaceutical Revenue in Small Molecule CXO Business (2018-2023)
11.7.5 Jiuzhou Pharmaceutical Recent Developments
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Details
11.8.2 Pharmaron Beijing Business Overview
11.8.3 Pharmaron Beijing Small Molecule CXO Introduction
11.8.4 Pharmaron Beijing Revenue in Small Molecule CXO Business (2018-2023)
11.8.5 Pharmaron Beijing Recent Developments
11.9 Porton Pharma
11.9.1 Porton Pharma Company Details
11.9.2 Porton Pharma Business Overview
11.9.3 Porton Pharma Small Molecule CXO Introduction
11.9.4 Porton Pharma Revenue in Small Molecule CXO Business (2018-2023)
11.9.5 Porton Pharma Recent Developments
11.10 ChemPartner
11.10.1 ChemPartner Company Details
11.10.2 ChemPartner Business Overview
11.10.3 ChemPartner Small Molecule CXO Introduction
11.10.4 ChemPartner Revenue in Small Molecule CXO Business (2018-2023)
11.10.5 ChemPartner Recent Developments
11.11 Tigermed
11.11.1 Tigermed Company Details
11.11.2 Tigermed Business Overview
11.11.3 Tigermed Small Molecule CXO Introduction
11.11.4 Tigermed Revenue in Small Molecule CXO Business (2018-2023)
11.11.5 Tigermed Recent Developments
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Details
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon Small Molecule CXO Introduction
11.12.4 Shanghai Medicilon Revenue in Small Molecule CXO Business (2018-2023)
11.12.5 Shanghai Medicilon Recent Developments
11.13 VIVA Biotech Holdings
11.13.1 VIVA Biotech Holdings Company Details
11.13.2 VIVA Biotech Holdings Business Overview
11.13.3 VIVA Biotech Holdings Small Molecule CXO Introduction
11.13.4 VIVA Biotech Holdings Revenue in Small Molecule CXO Business (2018-2023)
11.13.5 VIVA Biotech Holdings Recent Developments
11.14 Chengdu Hitgen
11.14.1 Chengdu Hitgen Company Details
11.14.2 Chengdu Hitgen Business Overview
11.14.3 Chengdu Hitgen Small Molecule CXO Introduction
11.14.4 Chengdu Hitgen Revenue in Small Molecule CXO Business (2018-2023)
11.14.5 Chengdu Hitgen Recent Developments
11.15 Nanjing Genscript
11.15.1 Nanjing Genscript Company Details
11.15.2 Nanjing Genscript Business Overview
11.15.3 Nanjing Genscript Small Molecule CXO Introduction
11.15.4 Nanjing Genscript Revenue in Small Molecule CXO Business (2018-2023)
11.15.5 Nanjing Genscript Recent Developments
11.16 ICON plc
11.16.1 ICON plc Company Details
11.16.2 ICON plc Business Overview
11.16.3 ICON plc Small Molecule CXO Introduction
11.16.4 ICON plc Revenue in Small Molecule CXO Business (2018-2023)
11.16.5 ICON plc Recent Developments
11.17 PRA Health
11.17.1 PRA Health Company Details
11.17.2 PRA Health Business Overview
11.17.3 PRA Health Small Molecule CXO Introduction
11.17.4 PRA Health Revenue in Small Molecule CXO Business (2018-2023)
11.17.5 PRA Health Recent Developments
11.18 Syneos Health
11.18.1 Syneos Health Company Details
11.18.2 Syneos Health Business Overview
11.18.3 Syneos Health Small Molecule CXO Introduction
11.18.4 Syneos Health Revenue in Small Molecule CXO Business (2018-2023)
11.18.5 Syneos Health Recent Developments
11.19 Lonza
11.19.1 Lonza Company Details
11.19.2 Lonza Business Overview
11.19.3 Lonza Small Molecule CXO Introduction
11.19.4 Lonza Revenue in Small Molecule CXO Business (2018-2023)
11.19.5 Lonza Recent Developments
11.20 Catalent
11.20.1 Catalent Company Details
11.20.2 Catalent Business Overview
11.20.3 Catalent Small Molecule CXO Introduction
11.20.4 Catalent Revenue in Small Molecule CXO Business (2018-2023)
11.20.5 Catalent Recent Developments
11.21 Thermo Fisher
11.21.1 Thermo Fisher Company Details
11.21.2 Thermo Fisher Business Overview
11.21.3 Thermo Fisher Small Molecule CXO Introduction
11.21.4 Thermo Fisher Revenue in Small Molecule CXO Business (2018-2023)
11.21.5 Thermo Fisher Recent Developments
11.22 DELPHARM
11.22.1 DELPHARM Company Details
11.22.2 DELPHARM Business Overview
11.22.3 DELPHARM Small Molecule CXO Introduction
11.22.4 DELPHARM Revenue in Small Molecule CXO Business (2018-2023)
11.22.5 DELPHARM Recent Developments
11.23 Aenova Group
11.23.1 Aenova Group Company Details
11.23.2 Aenova Group Business Overview
11.23.3 Aenova Group Small Molecule CXO Introduction
11.23.4 Aenova Group Revenue in Small Molecule CXO Business (2018-2023)
11.23.5 Aenova Group Recent Developments
11.24 Siegfried Holding AG
11.24.1 Siegfried Holding AG Company Details
11.24.2 Siegfried Holding AG Business Overview
11.24.3 Siegfried Holding AG Small Molecule CXO Introduction
11.24.4 Siegfried Holding AG Revenue in Small Molecule CXO Business (2018-2023)
11.24.5 Siegfried Holding AG Recent Developments
11.25 Recipharm AB
11.25.1 Recipharm AB Company Details
11.25.2 Recipharm AB Business Overview
11.25.3 Recipharm AB Small Molecule CXO Introduction
11.25.4 Recipharm AB Revenue in Small Molecule CXO Business (2018-2023)
11.25.5 Recipharm AB Recent Developments
11.26 FAREVA SA
11.26.1 FAREVA SA Company Details
11.26.2 FAREVA SA Business Overview
11.26.3 FAREVA SA Small Molecule CXO Introduction
11.26.4 FAREVA SA Revenue in Small Molecule CXO Business (2018-2023)
11.26.5 FAREVA SA Recent Developments
11.27 Almac Group
11.27.1 Almac Group Company Details
11.27.2 Almac Group Business Overview
11.27.3 Almac Group Small Molecule CXO Introduction
11.27.4 Almac Group Revenue in Small Molecule CXO Business (2018-2023)
11.27.5 Almac Group Recent Developments
11.28 Cambrex
11.28.1 Cambrex Company Details
11.28.2 Cambrex Business Overview
11.28.3 Cambrex Small Molecule CXO Introduction
11.28.4 Cambrex Revenue in Small Molecule CXO Business (2018-2023)
11.28.5 Cambrex Recent Developments
11.29 Charles River
11.29.1 Charles River Company Details
11.29.2 Charles River Business Overview
11.29.3 Charles River Small Molecule CXO Introduction
11.29.4 Charles River Revenue in Small Molecule CXO Business (2018-2023)
11.29.5 Charles River Recent Developments
11.30 CORDEN PHARMA
11.30.1 CORDEN PHARMA Company Details
11.30.2 CORDEN PHARMA Business Overview
11.30.3 CORDEN PHARMA Small Molecule CXO Introduction
11.30.4 CORDEN PHARMA Revenue in Small Molecule CXO Business (2018-2023)
11.30.5 CORDEN PHARMA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Small Molecule CXO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of CRO
Table 3. Key Players of CMC
Table 4. Key Players of CDMO
Table 5. Key Players of CMO
Table 6. Global Small Molecule CXO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Small Molecule CXO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Small Molecule CXO Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Small Molecule CXO Market Share by Region (2018-2023)
Table 10. Global Small Molecule CXO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Small Molecule CXO Market Share by Region (2024-2033)
Table 12. Small Molecule CXO Market Trends
Table 13. Small Molecule CXO Market Drivers
Table 14. Small Molecule CXO Market Challenges
Table 15. Small Molecule CXO Market Restraints
Table 16. Global Small Molecule CXO Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Small Molecule CXO Revenue Share by Players (2018-2023)
Table 18. Global Top Small Molecule CXO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CXO as of 2022)
Table 19. Global Small Molecule CXO Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Small Molecule CXO Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Small Molecule CXO, Headquarters and Area Served
Table 22. Global Key Players of Small Molecule CXO, Product and Application
Table 23. Global Key Players of Small Molecule CXO, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Small Molecule CXO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Small Molecule CXO Revenue Market Share by Type (2018-2023)
Table 27. Global Small Molecule CXO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Small Molecule CXO Revenue Market Share by Type (2024-2033)
Table 29. Global Small Molecule CXO Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Small Molecule CXO Revenue Share by Application (2018-2023)
Table 31. Global Small Molecule CXO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Small Molecule CXO Revenue Share by Application (2024-2033)
Table 33. North America Small Molecule CXO Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Small Molecule CXO Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Small Molecule CXO Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Small Molecule CXO Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Small Molecule CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Small Molecule CXO Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Small Molecule CXO Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Small Molecule CXO Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Small Molecule CXO Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Small Molecule CXO Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Small Molecule CXO Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Small Molecule CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Small Molecule CXO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Small Molecule CXO Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Small Molecule CXO Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Small Molecule CXO Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Small Molecule CXO Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Small Molecule CXO Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Small Molecule CXO Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Small Molecule CXO Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Small Molecule CXO Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Small Molecule CXO Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Small Molecule CXO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Small Molecule CXO Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Small Molecule CXO Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Small Molecule CXO Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Small Molecule CXO Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Small Molecule CXO Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Small Molecule CXO Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Small Molecule CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Small Molecule CXO Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Small Molecule CXO Market Size by Country (2024-2033) & (US$ Million)
Table 65. IQVIA Company Details
Table 66. IQVIA Business Overview
Table 67. IQVIA Small Molecule CXO Product
Table 68. IQVIA Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 69. IQVIA Recent Developments
Table 70. Labcorp Company Details
Table 71. Labcorp Business Overview
Table 72. Labcorp Small Molecule CXO Product
Table 73. Labcorp Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 74. Labcorp Recent Developments
Table 75. PPD Company Details
Table 76. PPD Business Overview
Table 77. PPD Small Molecule CXO Product
Table 78. PPD Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 79. PPD Recent Developments
Table 80. Wuxi Apptec Company Details
Table 81. Wuxi Apptec Business Overview
Table 82. Wuxi Apptec Small Molecule CXO Product
Table 83. Wuxi Apptec Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 84. Wuxi Apptec Recent Developments
Table 85. PharmaBlock Company Details
Table 86. PharmaBlock Business Overview
Table 87. PharmaBlock Small Molecule CXO Product
Table 88. PharmaBlock Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 89. PharmaBlock Recent Developments
Table 90. Asym Chemical Company Details
Table 91. Asym Chemical Business Overview
Table 92. Asym Chemical Small Molecule CXO Product
Table 93. Asym Chemical Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 94. Asym Chemical Recent Developments
Table 95. Jiuzhou Pharmaceutical Company Details
Table 96. Jiuzhou Pharmaceutical Business Overview
Table 97. Jiuzhou Pharmaceutical Small Molecule CXO Product
Table 98. Jiuzhou Pharmaceutical Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 99. Jiuzhou Pharmaceutical Recent Developments
Table 100. Pharmaron Beijing Company Details
Table 101. Pharmaron Beijing Business Overview
Table 102. Pharmaron Beijing Small Molecule CXO Product
Table 103. Pharmaron Beijing Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 104. Pharmaron Beijing Recent Developments
Table 105. Porton Pharma Company Details
Table 106. Porton Pharma Business Overview
Table 107. Porton Pharma Small Molecule CXO Product
Table 108. Porton Pharma Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 109. Porton Pharma Recent Developments
Table 110. ChemPartner Company Details
Table 111. ChemPartner Business Overview
Table 112. ChemPartner Small Molecule CXO Product
Table 113. ChemPartner Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 114. ChemPartner Recent Developments
Table 115. Tigermed Company Details
Table 116. Tigermed Business Overview
Table 117. Tigermed Small Molecule CXO Product
Table 118. Tigermed Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 119. Tigermed Recent Developments
Table 120. Shanghai Medicilon Company Details
Table 121. Shanghai Medicilon Business Overview
Table 122. Shanghai Medicilon Small Molecule CXO Product
Table 123. Shanghai Medicilon Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 124. Shanghai Medicilon Recent Developments
Table 125. VIVA Biotech Holdings Company Details
Table 126. VIVA Biotech Holdings Business Overview
Table 127. VIVA Biotech Holdings Small Molecule CXO Product
Table 128. VIVA Biotech Holdings Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 129. VIVA Biotech Holdings Recent Developments
Table 130. Chengdu Hitgen Company Details
Table 131. Chengdu Hitgen Business Overview
Table 132. Chengdu Hitgen Small Molecule CXO Product
Table 133. Chengdu Hitgen Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 134. Chengdu Hitgen Recent Developments
Table 135. Nanjing Genscript Company Details
Table 136. Nanjing Genscript Business Overview
Table 137. Nanjing Genscript Small Molecule CXO Product
Table 138. Nanjing Genscript Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 139. Nanjing Genscript Recent Developments
Table 140. ICON plc Company Details
Table 141. ICON plc Business Overview
Table 142. ICON plc Small Molecule CXO Product
Table 143. ICON plc Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 144. ICON plc Recent Developments
Table 145. PRA Health Company Details
Table 146. PRA Health Business Overview
Table 147. PRA Health Small Molecule CXO Product
Table 148. PRA Health Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 149. PRA Health Recent Developments
Table 150. Syneos Health Company Details
Table 151. Syneos Health Business Overview
Table 152. Syneos Health Small Molecule CXO Product
Table 153. Syneos Health Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 154. Syneos Health Recent Developments
Table 155. Lonza Company Details
Table 156. Lonza Business Overview
Table 157. Lonza Small Molecule CXO Product
Table 158. Lonza Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 159. Lonza Recent Developments
Table 160. Catalent Company Details
Table 161. Catalent Business Overview
Table 162. Catalent Small Molecule CXO Product
Table 163. Catalent Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 164. Catalent Recent Developments
Table 165. Thermo Fisher Company Details
Table 166. Thermo Fisher Business Overview
Table 167. Thermo Fisher Small Molecule CXO Product
Table 168. Thermo Fisher Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 169. Thermo Fisher Recent Developments
Table 170. DELPHARM Company Details
Table 171. DELPHARM Business Overview
Table 172. DELPHARM Small Molecule CXO Product
Table 173. DELPHARM Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 174. DELPHARM Recent Developments
Table 175. Aenova Group Company Details
Table 176. Aenova Group Business Overview
Table 177. Aenova Group Small Molecule CXO Product
Table 178. Aenova Group Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 179. Aenova Group Recent Developments
Table 180. Siegfried Holding AG Company Details
Table 181. Siegfried Holding AG Business Overview
Table 182. Siegfried Holding AG Small Molecule CXO Product
Table 183. Siegfried Holding AG Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 184. Siegfried Holding AG Recent Developments
Table 185. Recipharm AB Company Details
Table 186. Recipharm AB Business Overview
Table 187. Recipharm AB Small Molecule CXO Product
Table 188. Recipharm AB Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 189. Recipharm AB Recent Developments
Table 190. FAREVA SA Company Details
Table 191. FAREVA SA Business Overview
Table 192. FAREVA SA Small Molecule CXO Product
Table 193. FAREVA SA Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 194. FAREVA SA Recent Developments
Table 195. Almac Group Company Details
Table 196. Almac Group Business Overview
Table 197. Almac Group Small Molecule CXO Product
Table 198. Almac Group Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 199. Almac Group Recent Developments
Table 200. Cambrex Company Details
Table 201. Cambrex Business Overview
Table 202. Cambrex Small Molecule CXO Product
Table 203. Cambrex Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 204. Cambrex Recent Developments
Table 205. Charles River Company Details
Table 206. Charles River Business Overview
Table 207. Charles River Small Molecule CXO Product
Table 208. Charles River Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 209. Charles River Recent Developments
Table 210. CORDEN PHARMA Company Details
Table 211. CORDEN PHARMA Business Overview
Table 212. CORDEN PHARMA Small Molecule CXO Product
Table 213. CORDEN PHARMA Revenue in Small Molecule CXO Business (2018-2023) & (US$ Million)
Table 214. CORDEN PHARMA Recent Developments
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule CXO Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Small Molecule CXO Market Share by Type: 2022 VS 2033
Figure 3. CRO Features
Figure 4. CMC Features
Figure 5. CDMO Features
Figure 6. CMO Features
Figure 7. Global Small Molecule CXO Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Small Molecule CXO Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical Case Studies
Figure 10. Biotechnology Case Studies
Figure 11. Small Molecule CXO Report Years Considered
Figure 12. Global Small Molecule CXO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Small Molecule CXO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Small Molecule CXO Market Share by Region: 2022 VS 2033
Figure 15. Global Small Molecule CXO Market Share by Players in 2022
Figure 16. Global Top Small Molecule CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CXO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Small Molecule CXO Revenue in 2022
Figure 18. North America Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Small Molecule CXO Market Share by Type (2018-2033)
Figure 20. North America Small Molecule CXO Market Share by Application (2018-2033)
Figure 21. North America Small Molecule CXO Market Share by Country (2018-2033)
Figure 22. United States Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Small Molecule CXO Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Small Molecule CXO Market Share by Type (2018-2033)
Figure 26. Europe Small Molecule CXO Market Share by Application (2018-2033)
Figure 27. Europe Small Molecule CXO Market Share by Country (2018-2033)
Figure 28. Germany Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Small Molecule CXO Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Small Molecule CXO Market Share by Type (2018-2033)
Figure 36. China Small Molecule CXO Market Share by Application (2018-2033)
Figure 37. Asia Small Molecule CXO Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Small Molecule CXO Market Share by Type (2018-2033)
Figure 39. Asia Small Molecule CXO Market Share by Application (2018-2033)
Figure 40. Asia Small Molecule CXO Market Share by Region (2018-2033)
Figure 41. Japan Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Small Molecule CXO Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Small Molecule CXO Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Small Molecule CXO Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Small Molecule CXO Market Share by Country (2018-2033)
Figure 51. Brazil Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Small Molecule CXO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. IQVIA Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 58. Labcorp Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 59. PPD Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 60. Wuxi Apptec Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 61. PharmaBlock Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 62. Asym Chemical Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 63. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 64. Pharmaron Beijing Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 65. Porton Pharma Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 66. ChemPartner Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 67. Tigermed Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 68. Shanghai Medicilon Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 69. VIVA Biotech Holdings Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 70. Chengdu Hitgen Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 71. Nanjing Genscript Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 72. ICON plc Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 73. PRA Health Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 74. Syneos Health Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 75. Lonza Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 76. Catalent Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 77. Thermo Fisher Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 78. DELPHARM Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 79. Aenova Group Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 80. Siegfried Holding AG Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 81. Recipharm AB Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 82. FAREVA SA Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 83. Almac Group Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 84. Cambrex Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 85. Charles River Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 86. CORDEN PHARMA Revenue Growth Rate in Small Molecule CXO Business (2018-2023)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed